EUVIMEDEUVIMED entdecken
Crossref

ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death

Dario Priem, Jon Huyghe, Barbara Gilbert, Simon Verdonck, Tom Delanghe, Bruno Verstraeten, Esther Hoste, Peter Vandenabeele, Jonathan Maelfait, Geert van Loo, Mathieu J M Bertrand

Immunity · 2025-12 · 58 (12) · 2972-2988.e6

DOI: 10.1016/j.immuni.2025.09.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025-12. Verfasst von Dario Priem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation Research, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium. Electr…. Hauptthemen laut MEDLINE: Autophagy, Autophagy-Related Proteins, Membrane Proteins, Vesicular Transport Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Bijzonder Onderzoeksfonds UGent, Horizon 2020 Framework Programme, Government of Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor (TNF) is a central pro-inflammatory cytokine with pathologic roles in chronic inflammatory and autoimmune disorders. The mechanisms by which TNF sensing drives the pathogenesis of these diseases are not fully understood. We previously showed that the lack of the autophagic lipid scramblase ATG9A in mouse keratinocytes leads to severe dermatitis and systemic inflammation, with features resembling human skin disorders. We now demonstrate that the disease is initiated by TNF but caused by cGAS/STING-dependent type I interferon (IFN) production and subsequent ZBP1-dependent apoptosis and necroptosis. ATG9A prevented the pathogenesis of the disease by engaging both light-chain 3 (LC3)-dependent and -independent autophagy. These results uncover an additional pathological arm of TNF signaling, opening avenues for alternative therapeutic interventions for TNF-driven diseases. Moreover, this study reveals another pathophysiological function of LC3-independent autophagy in restraining type I IFN production, which triggers the development or exacerbation of an interferonopathy in mice and humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyAutophagy-Related ProteinsMembrane ProteinsVesicular Transport ProteinsDermatitisRNA-Binding ProteinsAnimalsMiceHumansInterferon Type IKeratinocytesMice, KnockoutSignal TransductionTumor Necrosis Factor-alphaNucleotidyltransferasesMicrotubule-Associated ProteinsMice, Inbred C57BLApoptosisSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

IFNTNFapoptosisautophagycell deathinflammatory diseasesinterferoninterferonopathynecroptosisskin inflammationsystemic lupus erythematosustumor necrosis factor

Substanzen

Autophagy-Related ProteinsMembrane ProteinsInterferon Type IVesicular Transport ProteinsTumor Necrosis Factor-alphaNucleotidyltransferasesMicrotubule-Associated ProteinsRNA-Binding ProteinsSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Center for Inflammation Research, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium. Electronic address: dario.priem@irc.vib-ugent.be.
  • Center for Inflammation Research, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
  • Center for Inflammation Research, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium. Electronic address: mathieu.bertrand@irc.vib-ugent.be.

Förderung

  • Bijzonder Onderzoeksfonds UGent
  • Horizon 2020 Framework Programme
  • Government of Flanders
  • Universiteit Gent
  • H2020 European Research Council
  • Research Foundation Flanders
  • Vlaams Instituut voor Biotechnologie
  • European Research Council

Zitieren

APA

Priem, D., Huyghe, J., Gilbert, B., Verdonck, S., Delanghe, T., Verstraeten, B., Hoste, E., Vandenabeele, P., Maelfait, J., van Loo, G., & Bertrand, M. J. M. (2025). ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death. Immunity, 58(12), 2972-2988.e6. https://doi.org/10.1016/j.immuni.2025.09.019

Vancouver

Priem D, Huyghe J, Gilbert B, Verdonck S, Delanghe T, Verstraeten B, et al. ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death. Immunity. 2025;58(12):2972-2988.e6. doi:10.1016/j.immuni.2025.09.019

BibTeX
@article{Priem2025,
  author = {Priem, Dario and Huyghe, Jon and Gilbert, Barbara and Verdonck, Simon and Delanghe, Tom and Verstraeten, Bruno and Hoste, Esther and Vandenabeele, Peter and Maelfait, Jonathan and van Loo, Geert and Bertrand, Mathieu J M},
  title = {ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death},
  journal = {Immunity},
  year = {2025},
  volume = {58},
  number = {12},
  pages = {2972--2988.e6},
  doi = {10.1016/j.immuni.2025.09.019}
}
Kostenlos starten →